AGUIAR ERIC
SEC insider (Form 3/4/5 filer). CIK 0001262325. Director at BridgeBio Pharma, Inc. (BBIO) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in SAN CARLOS, CA.
Companies AGUIAR ERIC has filed insider reports for
- BridgeBio Pharma, Inc. (BBIO): Director
- Biomea Fusion, Inc. (BMEA): Director
AGUIAR ERIC
CIK: 0001262325
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
AwardDirect4K shares- - Jun 10, 2026BMEA
Biomea Fusion, Inc.
AwardDirectStock Option (Right to Buy)
196.3K shares- - Jun 20, 2025BBIO
BridgeBio Pharma, Inc.
AwardDirect6.6K shares- - Jun 11, 2025BMEA
Biomea Fusion, Inc.
AwardDirectStock Option (Right to Buy)
92K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  BBIO BridgeBio Pharma, Inc. | Award | 3,990 | - | $0 | Direct |
| Jun 10, 2026 |  BMEA Biomea Fusion, Inc. | Award Stock Option (Right to Buy) | 196,299 | - | - | Direct |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | Award | 6,589 | - | - | Direct |
| Jun 11, 2025 | BMEA Biomea Fusion, Inc. | Award Stock Option (Right to Buy) | 91,970 | - | - | Direct |
1-4 of 4 transactions